The Egyptian journal of medical human genetics最新文献

{"title":"The role of tumor necrosis factor alpha - 308A > G polymorphism on the clinical states of SARS-CoV-2 infection.","authors":"Francisco Sotomayor-Lugo,&nbsp;Claudia Alemañy-Díaz Perera,&nbsp;Hilda Roblejo-Balbuena,&nbsp;Yaíma Zúñiga-Rosales,&nbsp;Giselle Monzón-Benítez,&nbsp;Beatriz Suárez-Besil,&nbsp;María de Los Ángeles González-Torres,&nbsp;Bárbara Torres-Rives,&nbsp;Yudelmis Álvarez-Gavilán,&nbsp;Maidalys Bravo-Ramírez,&nbsp;Nayade Pereira-Roche,&nbsp;Yudelkis Benítez-Cordero,&nbsp;Luis Carlos Silva-Ayçaguer,&nbsp;Beatriz Marcheco-Teruel","doi":"10.1186/s43042-022-00274-0","DOIUrl":"10.1186/s43042-022-00274-0","url":null,"abstract":"<p><strong>Background: </strong>Tumor necrosis factor-alpha (TNFɑ) is a cytokine that manages the host defense mechanism, which may play a role in the pathogenesis of COVID-19 patients. Several single-nucleotide polymorphisms, described in the promoter region of the TNFα gene, have a significant role on its transcriptional activity. These include the - 308A > G polymorphism which increases the TNFα levels with the expression of the A allele. The aim of this study was to explore whether the TNFα.- 308A > G polymorphism affects the clinical state of COVID-19 patients. The study included a total of 1028 individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which were distributed in 3 groups: asymptomatic, mild symptomatic and severe symptomatic patients. The amplification-refractory mutation system was used to determine the genotype of the TNFα.- 308A > G polymorphism.</p><p><strong>Results: </strong>Results show a higher tendency of being asymptomatic in individuals carrying the GG genotype (336 of 411; OR 1.24, 95% CI 0.91-1.70). The development of a severe form of SARS-CoV-2 infection was not found in subjects with the A allele compared to those with the G allele (OR 0.96, 95% CI 0.51-1.79), except in the eastern region of the country where the risk increased (OR 4.41, 95% CI 1.14-17.05). However, the subjects carrying the A allele had a higher chance of developing symptoms (OR 1.24, 95% CI 0.91-1.70) compared to those with the G allele.</p><p><strong>Conclusion: </strong>The TNFα.- 308A allele has an influence on developing symptoms of COVID-19 in Cuban patients, and that it particularly increases the risk of presenting severe forms of the disease in the eastern region of the country.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"55"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10277138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of angiotensin-converting enzyme 2 (<i>ACE2</i>) genetic variations in COVID-19 infection: a literature review.","authors":"Manal S Fawzy, Hend Ashour, Aya Allah Ashraf Shafie, Nesrine Ben Hadj Dahman, Abdelhamid M Fares, Sarah Antar, Ahmed S Elnoby, Fatma Mohamed Fouad","doi":"10.1186/s43042-022-00309-6","DOIUrl":"10.1186/s43042-022-00309-6","url":null,"abstract":"<p><strong>Background: </strong>The angiotensin-converting enzyme-2 (<i>ACE2</i>) is recognized to be the fundamental receptor of severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), responsible for the worldwide Coronavirus Disease-2019 (COVID-19) epidemic. However, genetic differences between people besides racial considerations and their relation to disease susceptibility are still not fully elucidated.</p><p><strong>Main body: </strong>To uncover the role of <i>ACE2</i> in COVID-19 infection, we reviewed the published studies that explore the association of COVID-19 with the functional characteristics of <i>ACE2</i> and its genetic variations. Notably, emerging studies tried to determine whether the <i>ACE2</i> variants and/or expression could be associated with SARS-CoV/SARS-CoV2 have conflicting results. Some researchers investigated the potential of \"population-specific\" <i>ACE2</i> genetic variations to impact the SARS-CoV2 vulnerability and suggested no ethnicity enrichment for <i>ACE2</i> polymorphisms that could influence SARS-CoV2 S-protein binding. At the same time, some studies use data mining to predict several <i>ACE2</i> variants that could enhance or decline susceptibility to SARS-CoV. On the other hand, fewer studies revealed an association of <i>ACE2</i> expression with COVID-19 outcome reporting higher expression levels of <i>ACE2</i> in East Asians.</p><p><strong>Conclusions: </strong><i>ACE2</i> gene variants and expression may modify the deleterious consequences of SARS-CoV2 to the host cells. It is worth noting that apart from the differences in gene expression and the genetic variations of <i>ACE2</i>, many other environmental and/or genetic factors could modify the disease outcome, including the genes for the innate and the adaptive immune response.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"97"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10268390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B.","authors":"Babak Sokouti","doi":"10.1186/s43042-022-00360-3","DOIUrl":"10.1186/s43042-022-00360-3","url":null,"abstract":"<p><strong>Background: </strong>Worldwide, COVID-19's death rate is about 2%, considering the incidence and mortality. However, the information on its complications in other organs, specifically the liver and its disorders, is limited in mild or severe cases. In this study, we aimed to computationally investigate the typical relationships between liver-related diseases [i.e., hepatocellular carcinoma (HCC), and chronic hepatitis B (CHB)] and COVID-19, considering the involved significant genes and their molecular mechanisms.</p><p><strong>Methods: </strong>We investigated two GEO microarray datasets (GSE164805 and GSE58208) to identify differentially expressed genes (DEGs) among the generated four datasets for mild/severe COVID-19, HCC, and CHB. Then, the overlapping genes among them were identified for GO and KEGG enrichment analyses, protein-protein interaction network construction, hub genes determination, and their associations with immune cell infiltration.</p><p><strong>Results: </strong>A total of 22 significant genes (i.e., ACTB, ATM, CDC42, DHX15, EPRS, GAPDH, HIF1A, HNRNPA1, HRAS, HSP90AB1, HSPA8, IL1B, JUN, POLR2B, PTPRC, RPS27A, SFRS1, SMARCA4, SRC, TNF, UBE2I, and VEGFA) were found to play essential roles among mild/severe COVID-19 associated with HCC and CHB. Moreover, the analysis of immune cell infiltration revealed that these genes are mostly positively correlated with tumor immune and inflammatory responses.</p><p><strong>Conclusions: </strong>In summary, the current study demonstrated that 22 identified DEGs might play an essential role in understanding the associations between the mild/severe COVID-19 patients with HCC and CHB. So, the HCC and CHB patients involved in different types of COVID-19 can benefit from immune-based targets for therapeutic interventions.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1186/s43042-022-00360-3.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"146"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9964938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SARS-CoV-2 origin, myths and diagnostic technology developments.","authors":"Josephine Wambani, Patrick Okoth","doi":"10.1186/s43042-022-00255-3","DOIUrl":"10.1186/s43042-022-00255-3","url":null,"abstract":"<p><strong>Background: </strong>After the first case of COVID-19 being announced in China in December 2019, various diagnostic technologies have been developed at unprecedented pace with the aim of providing a basis for accurate clinical intervention. However, some assays including CRISPR-based diagnostics and loop-mediated isothermal amplification (LAMP) have been less explored. As new COVID-19 technologies emerge, there is need for them to be assessed, validated and improved upon. Moreover, there is paucity of data on the essential factors governing the selection of an appropriate diagnostic approach within the correct timeframe. Myths and origin of SARS-CoV-2 remain to be controversial. Consequently, this review aims at exploring the current COVID-19 diagnostic technologies, performance evaluation, principles, suitability, specificity, sensitivity, successes and challenges of the technologies for laboratory and bedside testing.</p><p><strong>Main body: </strong>To date, there exist more publications on COVID-19 diagnostics as compared to the Zika virus. The SARS-CoV-2 virus genome profiles were readily available by 31st of December 2019. This was attributed to the fast-paced sharing of the epidemiological and diagnostics data of COVID-19. Timely profiling of the virus genome accelerated the development of diagnostic technologies. Furthermore, the rapid publication of studies that evaluated several diagnostic methods available provided baseline information on how the various technologies work and paved way for development of novel technologies.</p><p><strong>Conclusion: </strong>Up to date, RT-PCR is the most preferred as compared to the other assays. This is despite the repeated false negatives reported in many of the study findings. Considering that COVID-19 has caused devastating effects on the economy, healthcare systems, agriculture and culture, timely and accurate detection of the virus is paramount in the provision of targeted therapy hence reducing chances of drug resistance, increased treatment costs and morbidity. However, information on the origin of SARS-CoV-2 still remains elusive. Furthermore, knowledge and perception of the patients toward management of SARS-CoV-2 are also paramount to proper diagnosis and management of the pandemic. Future implications of the misperceptions are that they may lead to increased non-compliance to SARS-CoV-2-related World Health Organization (WHO) policies and guidelines.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"42"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9973678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The potential application of probiotics for the prevention and treatment of COVID-19.","authors":"Engy Elekhnawy, Walaa A Negm","doi":"10.1186/s43042-022-00252-6","DOIUrl":"10.1186/s43042-022-00252-6","url":null,"abstract":"<p><strong>Background: </strong>Given the severe infection, poor prognosis, and the low number of available effective drugs, potential prevention and treatment strategies for COVID-19 need to be urgently developed.</p><p><strong>Main body: </strong>Herein, we present and discuss the possible protective and therapeutic mechanisms of human microbiota and probiotics based on the previous and recent findings. Microbiota and probiotics consist of mixed cultures of living microorganisms that can positively affect human health through their antiviral, antibacterial, anti-inflammatory, and immunomodulatory effect. In the current study, we address the promising advantages of microbiota and probiotics in decreasing the risk of COVID-19.</p><p><strong>Conclusions: </strong>Thus, we recommend further studies be conducted for assessing and evaluating the capability of these microbes in the battle against COVID-19.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10268391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of COVID-19 pandemic lockdown on a sample of Egyptian children with Down syndrome.","authors":"Nagwa A Meguid,&nbsp;Neveen Hassan Nashaat,&nbsp;Hanaa Reyad Abdallah,&nbsp;Maha Hemimi,&nbsp;Ahmed Elnahry,&nbsp;Hazem Mohamed El-Hariri,&nbsp;Amal Elsaeid","doi":"10.1186/s43042-022-00280-2","DOIUrl":"10.1186/s43042-022-00280-2","url":null,"abstract":"<p><strong>Background: </strong>Down syndrome (DS) is characterized by variable degrees of intellectual disability (ID). The coronavirus disease-2019 (COVID-19) lockdown prevented children with DS from reaching their rehabilitation facilities. This could have led to deterioration of their abilities and mental health hazards. The aim of this cohort study was to investigate frequency of COVID-19, the influence of COVID-19 pandemic on health, and some abilities of children with DS, and to explore factors that could have governed receiving home-based training during the lockdown. A survey of 150 individuals with Down syndrome was answered by their caregivers. Additionally, 135 participants were subjected to assessment of cognitive, language, and motor abilities using Portage program. They were divided into 2 groups: group I who received online therapy sessions during the lockdown and group II who did not receive sessions. Logistic regression was used to determine the factors which influenced getting home-based training.</p><p><strong>Results: </strong>The percentage of COVID-19 cases was 3.3%. All evaluated abilities were reduced despite receiving online sessions particularly language performance (<i>P</i> < 0.001). Male gender, having severe ID and low parental education were among the factors which encouraged parents to get virtual training.</p><p><strong>Conclusion: </strong>COVID-19 pandemic had a negative impact on the abilities of DS children even those who got rehabilitation sessions. Their dependence on social interaction could have limited the benefit of virtual sessions. Factors that influence a parent's decision to get home-based training should be monitored and targeted in order to overcome obstacles or concepts that may prevent families from enduring home-based intervention.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"68"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10268388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Coronavirus-linked pregnancy complications: a comparative study.","authors":"Miapeh Kous Gonlepa,&nbsp;Olayemi Hafeez Rufai,&nbsp;Chidinmma Grace Ofuonye,&nbsp;Lapologang Sebaka","doi":"10.1186/s43042-022-00229-5","DOIUrl":"10.1186/s43042-022-00229-5","url":null,"abstract":"","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9964942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implication of single nucleotide polymorphisms in <i>Interleukin-10</i> gene (<i>rs1800896</i> and <i>rs1800872</i>) with severity of COVID-19.","authors":"Saliha Rizvi, S Mohd Shiraz Rizvi, Syed Tasleem Raza, Mohd Abbas, Kaynat Fatima, Zeashan H Zaidi, Farzana Mahdi","doi":"10.1186/s43042-022-00344-3","DOIUrl":"10.1186/s43042-022-00344-3","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) is an ongoing pandemic which has emerged as a new challenge for the medical sciences. Severity of COVID-19 is mostly determined with overexpressed proinflammatory cytokines eventually leading to endothelial dysfunction causing vital organ injury, especially in the lungs. It has been postulated that various genetic mutations might be associated with an increased risk of disease severity in COVID-19. This study was thus carried out to determine the association of <i>rs1800896 and rs1800872</i> genetic polymorphism in IL-10 gene in determining COVID-19 severity.</p><p><strong>Methods: </strong>The study included 160 RT-PCR confirmed COVID-19 patients with mild (<i>n</i> = 85) and severe (<i>n</i> = 75) conditions. All subjects were genotyped for <i>Interleukin-10</i> (<i>rs1800896 and rs1800872)</i> gene polymorphisms using PCR-RFLP technique followed by statistical analysis.</p><p><strong>Results: </strong>This study found a significant gender and age-based discrepancy in COVID-19 severity with 1.85-and 3.81-fold increased risk of COVID-19 in males of mild and severe groups as compared to females (<i>p</i> = 0.046 and <i>p</i> < 0.001) and 4.35-fold high risk in subjects ≥ 50 (<i>p</i> < 0.001). Genotyping analysis showed that <i>IL-10 (rs1800872)</i> gene polymorphism was strongly associated with COVID-19 severity (<i>p</i> = 0.01) whereas, <i>IL-10 rs1800896</i> polymorphism was not found to confer the risk of COVID-19 severity in our population.</p><p><strong>Conclusion: </strong>In this regard, the present study provided an evidence that <i>IL-10 (rs1800872)</i> gene polymorphism is strongly associated with COVID-19 severity and CC genotype confer a protective role in preventing severe disease progression. More detailed studies with a larger sample size on the genetic variations are required to establish the role of studied <i>IL-10</i> gene polymorphisms with COVID-19 severity.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"145"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9964944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach.","authors":"Arian Karimi Rouzbahani,&nbsp;Farnaz Kheirandish,&nbsp;Seyedeh Zeinab Hosseini","doi":"10.1186/s43042-022-00224-w","DOIUrl":"10.1186/s43042-022-00224-w","url":null,"abstract":"<p><strong>Background: </strong>As the new pandemic created by COVID-19 virus created the need of rapid acquisition of a suitable vaccine against SARS-CoV-2 to develop Immunity and to reduce the mortality, the aim of this study was to identify SARS-CoV-2 S protein and N antigenic epitopes by using immunoinformatic methods to design a vaccine against SARS-CoV-2, for which S and N protein-dependent epitopes are predicted. B cell, CTL and HTL were determined based on antigenicity, allergenicity and toxicity that were non-allergenic, non-toxic, and antigenic and were selected for the design of a multi-epitope vaccine structure. Then, in order to increase the safety of Hbd-3 and Hbd-2 as adjuvants, they were connected to the N and C terminals of the vaccine construct, respectively, with a linker. The three-dimensional structure of the structure was predicted and optimized, and its quality was evaluated. The vaccine construct was ligated to MHCI. Finally, after optimizing the codon to increase expression in <i>E. coli</i> K12, the vaccine construct was cloned into pET28a (+) vector.</p><p><strong>Results: </strong>Epitopes which were used in our survey were based on non-allergenic, non-toxic and antigenic. Therefore, 543-amino-acid-long multi-epitope vaccine formation was invented through linking 9 cytotoxic CTL, 5 HTL and 14 B cell epitopes with appropriate adjuvants and connectors that can control the SARS coronavirus 2 infection and could be more assessed in medical scientific researches.</p><p><strong>Conclusion: </strong>We believe that the proposed multi-epitope vaccine can effectively evoke an immune response toward SARS-CoV-2.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1186/s43042-022-00224-w.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"23 1","pages":"16"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9911009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A hybrid systems biology and systems pharmacology investigation of Zingerone's effects on reconstructed human epidermal tissues.","authors":"Elham Amjad,&nbsp;Babak Sokouti,&nbsp;Solmaz Asnaashari","doi":"10.1186/s43042-021-00204-6","DOIUrl":"https://doi.org/10.1186/s43042-021-00204-6","url":null,"abstract":"<p><strong>Background: </strong>As individuals live longer, elderly populations can be expected to face issues. This pattern urges researchers to investigate the aging concept further to produce successful anti-aging agents. In the current study, the effects of Zingerone (a natural compound) on epidermal tissues were analyzed using a bioinformatics approach.</p><p><strong>Methods: </strong>For this purpose, we chose the GEO dataset GSE133338 to carry out the systems biology and systems pharmacology approaches, ranging from identifying the differentially expressed genes to analyzing the gene ontology, determining similar structures of Zingerone and their features (i.e., anti-oxidant, anti-inflammatory, and skin disorders), constructing the gene-chemicals network, analyzing gene-disease relationships, and validating significant genes through the evidence presented in the literature.</p><p><strong>Results: </strong>The post-processing of the microarray dataset identified thirteen essential genes among control and Zingerone-treated samples. The procedure revealed various structurally similar chemical and herbal compounds with possible skin-related effects. Additionally, we studied the relationships of differentially expressed genes with skin-related diseases and validated their direct connections with skin disorders the evidence available in the literature. Also, the analysis of the microarray profiling dataset revealed the critical role of interleukins as a part of the cytokines family on skin aging progress.</p><p><strong>Conclusions: </strong>Zingerone, and potentially any constituents of Zingerone (e.g., their similar compound scan functionality), can be used as therapeutic agents in managing skin disorders such as skin aging. However, the beneficial effects of Zingerone should be assessed in other models (i.e., human or animal) in future studies.</p>","PeriodicalId":74994,"journal":{"name":"The Egyptian journal of medical human genetics","volume":"22 1","pages":"90"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10774193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}